N-PORT filing recap · June 2024
What did Longleaf Partners Global Fund buy in June 2024?
Reported stock-position changes between this filing and the previous one. These are Longleaf Partners Global Fund's own holdings, not the firm's.
Stock value
$239.56M
Positions
22
Estimated turnover
94.2%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
Period in review
Longleaf Partners Global Fund opened new positions in Exor, Millicom International Cellular, Prosus, Compagnie Financière Richemont, Eurofins Scientific, Bio-Rad Laboratories, Vivendi, Glanbia, Delivery Hero, Entain, and Accor. It also exited Bio-Rad Laboratories, Compagnie Financière Richemont, Delivery Hero, Accor, Eurofins Scientific, Glanbia, Exor, Prosus, and Millicom International Cellular. The fund trimmed CNX Resources and Live Nation Entertainment.